Skip to main content
Article thumbnail
Location of Repository

Degradation of cAMP-Responsive Element–Binding Protein by the Ubiquitin-Proteasome Pathway Contributes to Glucotoxicity in β-Cells and Human Pancreatic Islets

By Safia Costes, Brigitte Vandewalle, Cécile Tourrel-Cuzin, Christophe Broca, Nathalie Linck, Gyslaine Bertrand, Julie Kerr-Conte, Bernard Portha, François Pattou, Joel Bockaert and Stéphane Dalle
Topics: Original Article
Publisher: American Diabetes Association
OAI identifier: oai:pubmedcentral.nih.gov:2671045
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. A ˆ-Cell deficit and increased -cell apoptosis in humans with type 2 diabetes.
    2. (1994). Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.
    3. (1998). Altered bcl-2 and bax expression and intracellular Ca2 signaling in apoptosis of pancreatic cells and the impairment of glucose-induced insulin secretion. Endocrinology
    4. Banting Lecture 1995: A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm.
    5. (2003). cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev
    6. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes.
    7. Cooperative effects between protein kinase A and p44/p42 mitogenactivated protein kinase to promote cAMP-responsive element binding protein activation after beta cell stimulation by glucose and its alteration due to glucotoxicity.
    8. (1999). CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem
    9. Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells.
    10. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications.
    11. Dominant negative mutant forms of the cAMP response element binding protein induce apoptosis and decrease the anti-apoptotic action of growth factors inhuman islets.
    12. (2007). Emerging role of SUMO in pancreatic beta-cells. Horm Metab Res
    13. ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity.
    14. (2006). ERK1/2 control phosphorylation and protein level of cAMP-responsive element–binding protein: a key role in glucose-mediated pancreatic -cell survival. Diabetes
    15. Essential role of ubiquitinproteasome system in normal regulation of insulin secretion.
    16. Evidence for a role of the ubiquitin-proteasome pathway in pancreatic islets.
    17. (2005). Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 beta-cell line and islets of Langerhans. Endocrinology
    18. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells.
    19. Glucose toxicity in -cells: type 2 diabetes, good radicals gone bad, and the glutathione connection.
    20. In vivo protein transduction: delivery of a biologically active protein into the mouse.
    21. (2009). Influence of diabetes on the loss of beta cell differenciation after islet transplantation in rats.
    22. Influence of preservation solution on human islet isolation outcome.
    23. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback downregulates protein kinase B-mediated signaling pathway in beta-cells.
    24. Interventional strategies to prevent -cell apoptosis in islet transplantation.
    25. Islet beta cell failure in type 2 diabetes.
    26. Islet isolation assessment in man and large animals.
    27. Oxidative stress-mediated, posttranslational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells.
    28. (2004). Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt?
    29. Penicaud L: Mitochondrial reactive oxygen species are obligatory signals for glucose-induced insulin secretion.
    30. Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/ proteasome pathway in hypoxia.
    31. Proteasome inhibition alters glucose-stimulated (pro)insulin secretion and turnover in pancreatic {beta}-cells.
    32. (1999). Proteasomes in apoptosis: villains or guardians? Cell Mol Life Sci
    33. (2005). Protection of islets in culture by delivery of oxygen binding neuroglobin via protein transduction. Transplantation Proceedings
    34. Protein transduction technology offers a novel therapeutic approach for diabetes.
    35. (1998). Role of apoptosis in failure of -cell mass compensation for insulin resistance and -cell defects in the male Zucker diabetic fatty rat. Diabetes
    36. (2005). Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels.
    37. Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia.
    38. (1999). Substrate targeting in the ubiquitin system.
    39. Sumoylation regulates the transcriptional activity of MafA in pancreatic beta-cells.
    40. (2009). The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes ? Mol Cell Endocrinol
    41. The proteasome is required for rapid initiation of death receptor-induced apoptosis.
    42. (1998). The ubiquitin system. Annu Rev Biochem
    43. Type 2 diabetes-a matter of beta-cell life and death?

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.